Clinical Drug Development

Course Overview

Offered by UCL (University College London), the MRes Clinical Drug Development provides a comprehensive postgraduate education in architecture and the built environment. Based in Camden, England, this Russell Group university offers a research-led approach to learning, with a 1-year full-time structure. This one-year MRes acts as an effective foundation year for a research career in drug development and a comprehensive programme in research methodology. As well as deepening your knowledge of the latest techniques in drug development, you will gain practical experience by undertaking a significant research project, working with UCL's expert scientists. International tuition fees are £39,200 per year, home/UK fees are £18,400 per year, and a minimum IELTS score of 6.5 is required for admission. Graduates from this programme benefit from strong career prospects, with 82% student satisfaction rating, a median graduate salary of £33,000 within three years, a 95% continuation rate, and 73% of graduates in employment or further study.

What You'll Learn

Tuition Fees & Funding

UK tuition fees (2026/27) £18,400 Overseas tuition fees (2026/27) £39,200

Graduate Outcomes

Frequently Asked Questions